Indonesia to Follow Global Standards for Safe Covid-19 Vaccine Distribution

Indonesia’s Finance Minister shared that one of the plans is to create a simulation of a vaccination roll-out in Bogor, Bali, and Ambon, as advised by the country’s Ministry of Health.

The simulations are to give the government an idea of how to execute a Covid-19 vaccination program once the vaccine is ready.

Indonesia’s Ministry of Health is also conducting an evaluation of healthcare providers that either have or must equip themselves with cold storage facilities to avoid damaging the vaccines in accordance with WHO standards.

“According to the health ministry, 90 percent of all healthcare providers have met the WHO’s standards on cold storage facilities. We still need to provide more cold storage facilities to ensure that all future vaccines will be safely stored.”

Read also: Covax Initiative to Supply Covid-19 Vaccine to World’s Poor Faces Trouble

President Jokowi previously outlined the government’s swift move in distributing a coronavirus vaccine in Indonesia.

One reason is that Indonesia has been developing its own vaccine with the government in the final round of purchasing the vaccines from three producers: Cansino, G42/Sinopharm, and Sinovac.

However, all three manufacturers have yet to pass Phase 3 clinical trials.

Jokowi reiterated that the rush for a vaccine does not only apply to Indonesia, but to all countries as the global race for a coronavirus cure is in full gear.

The Indonesian President further explained that this global rush is to help their respective societies ward off the novel virus and restore individual economies.